| Casey Windrix, MD | |
|
920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104-5036 | |
| (405) 271-4351 | |
| (405) 271-8695 |
| Full Name | Casey Windrix |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 15 Years |
| Location | 920 Stanton L Young Blvd # Wp1140, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215162979 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 27185 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
| Entity Name | Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590974 PECOS PAC ID: 9830001650 Enrollment ID: O20050207000313 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
| Entity Name | Hospital Care Consultants Region Ii Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558491449 PECOS PAC ID: 8820197064 Enrollment ID: O20070727000300 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
| Entity Name | Medical Resource Management Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104056365 PECOS PAC ID: 4082753918 Enrollment ID: O20100830000840 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Casey Windrix, MD Po Box 26901, Oklahoma City, OK 73126-0901 Ph: (405) 271-4351 | Casey Windrix, MD 920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104-5036 Ph: (405) 271-4351 |
News Archive
Genta Incorporated today announced that the U.S. Food and Drug Administration (FDA) has granted the Company's request for "Fast Track" designation of tesetaxel for treatment of patients with advanced gastric cancer. Tesetaxel - a late Phase 2 oncology product - is the leading oral taxane currently in clinical development.
Orexo AB and Novo A/S today announced combined transactions encompassing a directed new issue by Orexo of a SEK 111 million convertible bond to Denmark-based Novo A/S and the acquisition of significant blocks of existing shares by Novo A/S from two existing venture capital shareholders, subject to approval at an Extraordinary General Meeting. The conversion price of the convertible bonds is set at 25 per cent premium to the closing share price on 12 March, 2010.
A new study by Massachusetts General Hospital investigators released today in JAMA Network Open, a publication of the Journal of the American Medical Association, showed that labeling food choices in a hospital cafeteria with simple "traffic-light" symbols indicating their relative health value was associated with a reduction in calories purchased by employees, and that the dietary changes were sustained over two years.
David Joel Perea called from Maine, Vermont, Minnesota and, ultimately, Nevada, always with the same request: "Mom, can you send tamales?" Dominga Perea would ship them overnight.
› Verified 6 days ago
Dr. Elizabeth Anne Williams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6201 Beaver Creek Rd, Oklahoma City, OK 73162 Phone: 405-210-4198 Fax: 405-703-7595 | |
Dr. Steven J Lantier, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9500 Broadway Ext, Oklahoma City, OK 73114 Phone: 405-475-0680 | |
Dr. Martin J Lopez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4525 S Klein Ave, Ste 900, Oklahoma City, OK 73109 Phone: 405-636-1797 | |
Betty J Haywood, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 750 Ne 13th St, Oac 200, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 | |
Dr. Suhal S Mahid, MD, PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Lee Ave, Oklahoma City, OK 73102 Phone: 405-272-8000 | |
Dr. Lauren L. Fitzgerald, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 918-392-2944 Fax: 918-664-2521 | |
Sathish Ramanathan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 |